<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Whisper From Wall Street &#187; grant-zeng</title>
	<atom:link href="http://whisperfromwallstreet.com/blog/tag/grant-zeng/feed/" rel="self" type="application/rss+xml" />
	<link>http://whisperfromwallstreet.com/blog</link>
	<description></description>
	<lastBuildDate>Fri, 10 Jun 2011 15:10:21 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.1</generator>
		<item>
		<title>Zacks Industry Outlook Highlights: BioMarin, Onyx, Celgene and AMAG</title>
		<link>http://whisperfromwallstreet.com/blog/zacks-industry-outlook-highlights-biomarin-onyx-celgene-and-amag/</link>
		<comments>http://whisperfromwallstreet.com/blog/zacks-industry-outlook-highlights-biomarin-onyx-celgene-and-amag/#comments</comments>
		<pubDate>Mon, 26 Jan 2009 10:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Todays Watchlist]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[discusses-the-biotech]]></category>
		<category><![CDATA[getib]]></category>
		<category><![CDATA[grant]]></category>
		<category><![CDATA[grant-zeng]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[latest]]></category>
		<category><![CDATA[the-market]]></category>
		<category><![CDATA[today-issued]]></category>
		<category><![CDATA[wire]]></category>
		<category><![CDATA[zacks]]></category>

		<guid isPermaLink="false">http://whisperfromwallstreet.com/blog/zacks-industry-outlook-highlights-biomarin-onyx-celgene-and-amag/</guid>
		<description><![CDATA[CHICAGO--(BUSINESS WIRE)--Zacks.com announces the latest Industry Outlook. Today&#8217;s outlook from Zacks Equity Research analyst Grant Zeng discusses the Biotech sector. Highlighted stocks include: BioMarin]]></description>
		<wfw:commentRss>http://whisperfromwallstreet.com/blog/zacks-industry-outlook-highlights-biomarin-onyx-celgene-and-amag/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

